{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T22:46:26Z","timestamp":1776725186624,"version":"3.51.2"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04157-5","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T14:48:25Z","timestamp":1747147705000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Renometabolic disorder in experimental rat model of polycystic ovarian syndrome is reversed by acetate-mediated inhibition of pyruvate dehydrogenase kinase 4"],"prefix":"10.1186","volume":"26","author":[{"given":"Stephanie E.","family":"Areloegbe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chukwubueze L.","family":"Atuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayodeji","family":"Aturamu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaac O.","family":"Ajadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oluseyi E.","family":"Adelekan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary B.","family":"Ajadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher O.","family":"Akintayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria O.","family":"Omoruyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel O.","family":"Onyekweli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omosola F.","family":"Anifowose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oluwatobi A.","family":"Amusa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayode","family":"Ajayi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Oyewole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tolulope E.","family":"Adegoke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8229-9688","authenticated-orcid":false,"given":"Kehinde S.","family":"Olaniyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"key":"4157_CR1","doi-asserted-by":"crossref","unstructured":"Hatoum S, Amiri M, Hopkins D, Buyalos RP, Bril F, Azziz R. SAT365 prevalence of polycystic ovary syndrome (PCOS) in health system and insurer records vs. the prevalence in the population: evidence for the significant underdiagnosis and undertreatment of PCOS. J Endocrine Soc. 2023 Oct;7(Supplement_1).","DOI":"10.1210\/jendso\/bvad114.1670"},{"issue":"2","key":"4157_CR2","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41390-019-0615-1","volume":"87","author":"SF Witchel","year":"2020","unstructured":"Witchel SF, Teede HJ, Pe\u00f1a AS. Curtailing pcos. Pediatr Res. 2020 Jan;87(2):353\u201361.","journal-title":"Pediatr Res"},{"key":"4157_CR3","doi-asserted-by":"crossref","unstructured":"Joham AE, Norman RJ, Stener-Victorin E, Legro RS, Franks S, Moran LJ, Boyle J, Teede HJ. Polycystic ovary syndrome. Lancet Diabetes Endocrinol. 2022 Sep 1;10(9):668\u201380.","DOI":"10.1016\/S2213-8587(22)00163-2"},{"issue":"8","key":"4157_CR4","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.3390\/diagnostics12081931","volume":"12","author":"AS Pe\u00f1a","year":"2022","unstructured":"Pe\u00f1a AS, Codner E, Witchel S.Criteria for diagnosis of polycystic ovary syndrome during adolescence: literature review. Diagnostics. 2022;12(8):1931.","journal-title":"Diagnostics"},{"issue":"3","key":"4157_CR5","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1007\/s43032-021-00515-4","volume":"29","author":"V Bruni","year":"2022","unstructured":"Bruni V, Capozzi A, Lello S. The role of genetics, epigenetics and lifestyle in polycystic ovary syndrome development: the state of the art. Reprod Sci. 2022 Mar;29(3):668\u201379.","journal-title":"Reprod Sci"},{"issue":"3","key":"4157_CR6","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1007\/s43032-022-01013-x","volume":"30","author":"VV Smirnov","year":"2023","unstructured":"Smirnov VV, Beeraka NM, Butko DY, Nikolenko VN, Bondarev SA, Achkasov EE, Sinelnikov MY, Vikram PH. Updates on molecular targets and epigenetic-based therapies for PCOS. Reprod Sci. 2023 Mar;30(3):772\u201386.","journal-title":"Reprod Sci"},{"key":"4157_CR7","first-page":"1","volume":"22","author":"Y Feng","year":"2024","unstructured":"Feng Y, Li M, Li X, Tang Q, Li X, Ji X, Tian W, Zhang H. Characteristics of different obesity metabolic indexes and their correlation with insulin resistance in patients with polycystic ovary syndrome. Reprod Sci. 2024;22:1\u20137.","journal-title":"Reprod Sci"},{"issue":"6","key":"4157_CR8","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/humupd\/dmaa029","volume":"26","author":"V Wekker","year":"2020","unstructured":"Wekker V, Van Dammen L, Koning A, Heida KY, Painter RC, Limpens J, Laven JS, van Lennep Je R, Roseboom TJ, Hoek A. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis. Human Reproduction Update. 2020 Nov;26(6):942\u201360.","journal-title":"Human Reproduction Update"},{"key":"4157_CR9","doi-asserted-by":"crossref","unstructured":"Zhu T, Cui J, Goodarzi MO. Polycystic ovary syndrome and risk of type 2 diabetes, coronary heart disease, and stroke. Diabetes. 2021 Feb 1;70(2):627\u201337.","DOI":"10.2337\/db20-0800"},{"key":"4157_CR10","doi-asserted-by":"crossref","unstructured":"Olaniyi KS, Bashir AA, Areloegbe SE, Sabinari IW, Akintayo CO, Oniyide AA, Aturamu A. Short chain fatty acid, acetate restores ovarian function in experimentally induced PCOS rat model. PLoS One. 2022 Jul 26;17(7).","DOI":"10.1371\/journal.pone.0272124"},{"issue":"2","key":"4157_CR11","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s40200-022-01097-x","volume":"21","author":"EG Uhunmwangho","year":"2022","unstructured":"Uhunmwangho EG, Oniyide AA, Areloegbe SE, Soetan OA, Akintayo CO, Aturamu A, Olaniyi KS. Mineralocorticoid receptor blockade attenuates hyperandrogenic metabolic dysregulation in letrozole-induced PCOS rat model. J Diabetes Metab Disord. 2022 Dec;21(2):1539\u201347.","journal-title":"J Diabetes Metab Disord"},{"key":"4157_CR12","doi-asserted-by":"crossref","unstructured":"Zeng X, Xie YJ, Liu YT, Long SL, Mo ZC. Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity. Clin Chim Acta. 2020 Mar 1;502:214\u201321.","DOI":"10.1016\/j.cca.2019.11.003"},{"key":"4157_CR13","doi-asserted-by":"crossref","unstructured":"Palmer BF, Clegg DJ. Starvation ketosis and the kidney. Am J Nephrol. 2021 Aug 26;52(6):467\u201378.","DOI":"10.1159\/000517305"},{"issue":"4","key":"4157_CR14","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1007\/s13679-024-00583-y","volume":"13","author":"D Kounatidis","year":"2024","unstructured":"Kounatidis D, Vallianou NG, Stratigou T, Voukali M, Karampela I, Dalamaga M. The kidney in obesity: current evidence, perspectives and controversies. Current Obesity Reports. 2024 Dec;13(4):680\u2013702.","journal-title":"Current Obesity Reports"},{"key":"4157_CR15","doi-asserted-by":"crossref","unstructured":"Stasi A, Cosola C, Caggiano G, Cimmarusti MT, Palieri R, Acquaviva PM, Rana G, Gesualdo L. Obesity-related chronic kidney disease: principal mechanisms and new approaches in nutritional management. Frontiers in Nutrition. 2022 Jun 24; 9:925619.","DOI":"10.3389\/fnut.2022.925619"},{"key":"4157_CR16","doi-asserted-by":"crossref","unstructured":"Bannigida DM, Nayak BS, Vijayaraghavan R. Insulin resistance and oxidative marker in women with PCOS. Archives Physiol Biochem. 2020 Mar 14; 126(2):183\u201386.","DOI":"10.1080\/13813455.2018.1499120"},{"key":"4157_CR17","doi-asserted-by":"crossref","unstructured":"Rostami Dovom M, Rahmati M, Amanollahi Soudmand S, Ziaeefar P, Azizi F, Ramezani Tehrani F. The hidden link between polycystic ovary syndrome and kidney stones: finding from the Tehran lipid and glucose study (TLGS). Diagnostics. 2023 Aug 30;13(17):2814.","DOI":"10.3390\/diagnostics13172814"},{"key":"4157_CR18","doi-asserted-by":"crossref","unstructured":"Bashir AA, Olaniyi KS. Butyrate alleviates renal inflammation and fibrosis in a rat model of polycystic ovarian syndrome by suppression of SDF-1. BMC Pharmacol Toxicol. 2023 Oct 3;24(1):48.","DOI":"10.1186\/s40360-023-00692-9"},{"key":"4157_CR19","doi-asserted-by":"crossref","unstructured":"Gungor K, Gungor ND, Celik O, Ersahin A, Celik N, Yardim M, Yurci A, Kobaner M, Ilkov Maslarski I. Polycystic ovary syndrome accompanied by hyperandrogenemia or metabolic syndrome triggers glomerular podocyte injury. Diagnostics. 2024 Oct 1;14(19):2197.","DOI":"10.3390\/diagnostics14192197"},{"issue":"1","key":"4157_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/ckj\/sfx147","volume":"11","author":"GB Piccoli","year":"2018","unstructured":"Piccoli GB, Alrukhaimi M, Liu ZH, Zakharova E, Levin A. World kidney day steering committee. Women and kidney disease: reflections on World Kidney Day 2018. Clin Kidney J. 2018 Feb;11(1):7\u201311.","journal-title":"Clin Kidney J"},{"key":"4157_CR21","doi-asserted-by":"crossref","unstructured":"Peter MU, Areloegbe SE, Akintayo CO, Oniyide AA, Aturamu A, Olaniyi KS. Low-dose spironolactone abates cardio-renal disorder by reduction of BAX\/inflammasome expression in experimentally induced polycystic ovarian syndrome rat model. Can J Physiol Pharmacol. 2022 Jun 30;100(9):890\u2013902.","DOI":"10.1139\/cjpp-2022-0176"},{"key":"4157_CR22","doi-asserted-by":"crossref","unstructured":"Li J, Yu C, Shen F, Cui B, Liu N, Zhuang S. Class IIa histone deacetylase inhibition ameliorates acute kidney injury by suppressing renal tubular cell apoptosis and enhancing autophagy and proliferation. Front Pharmacol. 2022 Jul 22;13:946192.","DOI":"10.3389\/fphar.2022.946192"},{"key":"4157_CR23","doi-asserted-by":"crossref","unstructured":"Olaniyi KS, Areloegbe SE. Acetate circumvents impaired metabolic switch in skeletal muscle of letrozole-induced PCOS rat model by suppression of PDK4\/NLRP3. Nutrition. 2023 Mar 1;107:111914.","DOI":"10.1016\/j.nut.2022.111914"},{"key":"4157_CR24","doi-asserted-by":"crossref","unstructured":"Stacpoole PW, McCall CE. The pyruvate dehydrogenase complex: life\u2019s essential, vulnerable and druggable energy homeostat. Mitochondrion. 2023 May 1;70:59\u2013102.","DOI":"10.1016\/j.mito.2023.02.007"},{"key":"4157_CR25","doi-asserted-by":"crossref","unstructured":"Takemura K, Nishi H, Inagi R. Mitochondrial dysfunction in kidney disease and uremic sarcopenia. Front Physiol. 2020 Sep 4;11:565023.","DOI":"10.3389\/fphys.2020.565023"},{"issue":"2","key":"4157_CR26","first-page":"187","volume":"48","author":"N Forghani","year":"2023","unstructured":"Forghani N, Karimi Z, Mokhtari M, Shariati M, Masjedi F. Association of Oxidative Stress with Kidney Injury in a hyperandrogenemic female rat model. Iran J Med Sci. 2023 Mar;48(2):187.","journal-title":"Iran J Med Sci"},{"key":"4157_CR27","doi-asserted-by":"crossref","unstructured":"N\u00f8rg\u00e5rd M\u00d8, Svenningsen P. Acute kidney injury by ischemia\/reperfusion and extracellular vesicles. Int J Mol Sci. 2023 Oct 18;24(20):15312.","DOI":"10.3390\/ijms242015312"},{"key":"4157_CR28","doi-asserted-by":"crossref","unstructured":"Oh CJ, Kim MJ, Lee JM, Kim DH, Kim IY, Park S, Kim Y, Lee KB, Lee SH, Lim CW, Kim M. Inhibition of pyruvate dehydrogenase kinase 4 ameliorates kidney ischemia-reperfusion injury by reducing succinate accumulation during ischemia and preserving mitochondrial function during reperfusion. Kidney Int. 2023 Oct 1;104(4):724\u201339.","DOI":"10.1016\/j.kint.2023.06.022"},{"key":"4157_CR29","doi-asserted-by":"crossref","unstructured":"Kim MJ, Sinam IS, Siddique Z, Jeon JH, Lee IK. The link between mitochondrial dysfunction and sarcopenia: an update focusing on the role of pyruvate dehydrogenase kinase 4. Diabet Metabol J. 2023 Jan 12;47(2):153\u201363.","DOI":"10.4093\/dmj.2022.0305"},{"key":"4157_CR30","doi-asserted-by":"crossref","unstructured":"Tian S, Yang X, Lin Y, Li X, Zhou S, Yu P, Zhao Y. PDK4-mediated Nrf2 inactivation contributes to oxidative stress and diabetic kidney injury. Cell Signalling. 2024 Sep 1;121:111282.","DOI":"10.1016\/j.cellsig.2024.111282"},{"key":"4157_CR31","doi-asserted-by":"crossref","unstructured":"De Vos WM, Tilg H, Van Hul M, Cani PD. Gut microbiome and health: mechanistic insights. Gut. 2022 May 1;71(5):1020\u201332.","DOI":"10.1136\/gutjnl-2021-326789"},{"key":"4157_CR32","doi-asserted-by":"crossref","unstructured":"Areloegbe SE, Olaniyi KS. Acetate mitigates cardiac mitochondrial dysfunction in experimental model of polycystic ovarian syndrome by modulating GPCR41\/43 and PROKR1. Biochem Biophys Res Commun. 2023 Nov 12;681:62\u201372.","DOI":"10.1016\/j.bbrc.2023.09.061"},{"key":"4157_CR33","doi-asserted-by":"crossref","unstructured":"Ikeda T, Nishida A, Yamano M, Kimura I. Short-chain fatty acid receptors and gut microbiota as therapeutic targets in metabolic, immune, and neurological diseases. Pharmacol Ther. 2022 Nov 1;239:108273.","DOI":"10.1016\/j.pharmthera.2022.108273"},{"issue":"12","key":"4157_CR34","doi-asserted-by":"publisher","first-page":"5524","DOI":"10.1039\/D0FO02890H","volume":"12","author":"B Li","year":"2021","unstructured":"Li B, He X, Jin HY, Wang HY, Zhou FC, Zhang NY, Jie DY, Li LZ, Su J, Zheng X, Luo R.Beneficial effects of Dendrobium officinale on metabolic hypertensive rats by triggering the enteric-origin SCFA-GPCR43\/41 pathway. Food Funct. 2021;12(12):5524\u201338.","journal-title":"Food Funct"},{"issue":"5","key":"4157_CR35","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41574-019-0156-z","volume":"15","author":"EE Canfora","year":"2019","unstructured":"Canfora EE, Meex RC, Venema K, Blaak EE. Gut microbial metabolites in obesity, NAFLD and T2DM. Nat Rev Endocrinol. 2019 May;15(5):261\u201373.","journal-title":"Nat Rev Endocrinol"},{"key":"4157_CR36","doi-asserted-by":"crossref","unstructured":"Liu L, Fu C, Li F. Acetate affects the process of lipid metabolism in rabbit liver, skeletal muscle and adipose tissue. Animals. 2019 Oct 14;9(10):799.","DOI":"10.3390\/ani9100799"},{"issue":"6","key":"4157_CR37","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/ijo.2016.23","volume":"40","author":"M Sahuri-Arisoylu","year":"2016","unstructured":"Sahuri-Arisoylu M, Brody LP, Parkinson JR, Parkes H, Navaratnam N, Miller AD, Thomas EL, Frost G, Bell JD. Reprogramming of hepatic fat accumulation and\u2019browning\u2019of adipose tissue by the short-chain fatty acid acetate. Int J Obesity. 2016 Jun;40(6):955\u201363.","journal-title":"Int J Obesity"},{"issue":"2","key":"4157_CR38","first-page":"239","volume":"32","author":"KS Olaniyi","year":"2023","unstructured":"Olaniyi KS, Amusa OA, Areloegbe SE, Ajadi IO, Aladeyelu OS, Ajadi MB. Modulatory effect of PPAR-\u03b3 by acetate on cardiorenometabolic disturbance associated with high fat diet\u2013fed insulin-resistant male Wistar rats. Comp Clin Pathol. 2023 Apr;32(2):239\u201352.","journal-title":"Comp Clin Pathol"},{"key":"4157_CR39","doi-asserted-by":"crossref","unstructured":"Prajapati DP, Patel M, Dharamsi A. Beneficial effect of polyherbal formulation in letrozole induced polycystic ovarian syndrome (PCOS). J Traditional Complementary Med. 2022 Nov 1;12(6):575\u201383.","DOI":"10.1016\/j.jtcme.2022.08.003"},{"issue":"6","key":"4157_CR40","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1177\/0192623315570339","volume":"43","author":"MC Cora","year":"2015","unstructured":"Cora MC, Kooistra L, Travlos G. Vaginal cytology of the laboratory rat and mouse: review and criteria for the staging of the estrous cycle using stained vaginal smears. Toxicol Pathol. 2015 Aug;43(6):776\u201393.","journal-title":"Toxicol Pathol"},{"key":"4157_CR41","doi-asserted-by":"crossref","unstructured":"Lovick TA, Zangrossi Jr H. Effect of estrous cycle on behavior of females in rodent tests of anxiety. Frontiers Psychiatry. 2021 Aug 31;12:711065.","DOI":"10.3389\/fpsyt.2021.711065"},{"key":"4157_CR42","doi-asserted-by":"crossref","unstructured":"Olaniyi KS, Areloegbe SE, Fiemotongha FE. Cardiac energy depletion in a rat model of polycystic ovarian syndrome is reversed by acetate and associated with inhibitory effect of HDAC2\/mTOR. Eur J Pharmacol. 2024 Jan 5;962:176243.","DOI":"10.1016\/j.ejphar.2023.176243"},{"key":"4157_CR43","doi-asserted-by":"crossref","unstructured":"Kiyatkin EA, Brown PL. Brain and body temperature homeostasis during sodium pentobarbital anesthesia with and without body warming in rats. Physiol Behav. 2005 Mar 31;84(4):563\u201370.","DOI":"10.1016\/j.physbeh.2005.02.002"},{"key":"4157_CR44","doi-asserted-by":"crossref","unstructured":"Mohamed AS, Hosney M, Bassiony H, Hassanein SS, Soliman AM, Fahmy SR, Gaafar K. Sodium pentobarbital dosages for exsanguination affect biochemical, molecular and histological measurements in rats. Sci Rep. 2020 Jan 15;10(1):378.","DOI":"10.1038\/s41598-019-57252-7"},{"key":"4157_CR45","doi-asserted-by":"crossref","unstructured":"Johnson MK, Clark TD, Njama-Meya D, Rosenthal PJ, Parikh S. Impact of the method of G6PD deficiency assessment on genetic association studies of malaria susceptibility. PloS One. 2009 Sep 30;4(9).","DOI":"10.1371\/journal.pone.0007246"},{"key":"4157_CR46","doi-asserted-by":"crossref","unstructured":"Olaniyi KS, Areloegbe SE. Acetate: a therapeutic candidate against renal disorder in a rat model of polycystic ovarian syndrome. J Steroid Biochem Mol Biol. 2023 Jan 1;225:106179.","DOI":"10.1016\/j.jsbmb.2022.106179"},{"issue":"2","key":"4157_CR47","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1177\/0192623319877871","volume":"48","author":"F Hu","year":"2020","unstructured":"Hu F, Schutt L, Kozlowski C, Regan K, Dybdal N, Schutten MM. Ovarian toxicity assessment in histopathological images using deep learning. Toxicol Pathol. 2020 Feb;48(2):350\u201361.","journal-title":"Toxicol Pathol"},{"key":"4157_CR48","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/BF00381883","volume":"270","author":"S Malamed","year":"1992","unstructured":"Malamed S, Gibney JA, Ojeda SR. Ovarian innervation develops before initiation of folliculogenesis in the rat. Cell Tissue Res. 1992;270:87\u201393.","journal-title":"Cell Tissue Res"},{"issue":"4","key":"4157_CR49","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1161\/01.HYP.34.4.854","volume":"34","author":"JE Toblli","year":"1999","unstructured":"Toblli JE, Ferder L, Angerosa M, Inserra F. Effects of amlodipine on tubulointerstitial lesions in normotensive hyperoxaluric rats. Hypertension. 1999 Oct;34(4):854\u201358.","journal-title":"Hypertension"},{"key":"4157_CR50","doi-asserted-by":"crossref","unstructured":"Du Y, Li F, Li S, Ding L, Liu M. Causal relationship between polycystic ovary syndrome and chronic kidney disease: a Mendelian randomization study. Front Endocrinol. 2023 Mar 15;14:1120119.","DOI":"10.3389\/fendo.2023.1120119"},{"issue":"1","key":"4157_CR51","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1267\/ahc.21-00081","volume":"55","author":"AA Morsi","year":"2022","unstructured":"Morsi AA, Mersal EA, Farrag ARH, Abdelmoneim AM, Abdelmenem AM, Salim MS.Histomorphological changes in a rat model of polycystic ovary syndrome and the contribution of Stevia leaf extract in modulating the ovarian fibrosis, VEGF, and TGF-\u03b2 immunoexpressions: comparison with metformin. Acta Histochemica Et Cytochemica. 2022;55(1):9\u201323.","journal-title":"Acta Histochemica Et Cytochemica"},{"key":"4157_CR52","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/nep.13147","volume":"22","author":"H Xu","year":"2017","unstructured":"Xu H, Carrero JJ. Insulin resistance in chronic kidney disease. Nephrology. 2017;22:31\u201334.","journal-title":"Nephrology"},{"key":"4157_CR53","doi-asserted-by":"crossref","unstructured":"Yoon J, Heo SJ, Lee JH, Kwon YJ, Lee JE. Comparison of METS-IR and HOMA-IR for predicting new-onset CKD in middle-aged and older adults. Diabetol Metab Syndr. 2023 Nov 14;15(1):230.","DOI":"10.1186\/s13098-023-01214-7"},{"key":"4157_CR54","doi-asserted-by":"crossref","unstructured":"Yang A, Mottillo EP. Adipocyte lipolysis: from molecular mechanisms of regulation to disease and therapeutics. Biochem J. 2020 Mar 13;477(5):985\u20131008.","DOI":"10.1042\/BCJ20190468"},{"key":"4157_CR55","doi-asserted-by":"crossref","unstructured":"Carlstr\u00f6m M. Nitric oxide signalling in kidney regulation and cardiometabolic health. Nat Rev Nephrol. 2021 Sep;17(9):575\u201390.","DOI":"10.1038\/s41581-021-00429-z"},{"key":"4157_CR56","doi-asserted-by":"crossref","unstructured":"Lv W, Booz GW, Fan F, Wang Y, Roman RJ. Oxidative stress and renal fibrosis: recent insights for the development of novel therapeutic strategies. Front Physiol. 2018 Feb 16;9:105.","DOI":"10.3389\/fphys.2018.00105"},{"key":"4157_CR57","doi-asserted-by":"crossref","unstructured":"Zhou X, Chen H, Shi Y, Ma X, Zhuang S, Liu N. The role and mechanism of histone deacetylases in acute kidney injury. Front Pharmacol. 2021 Jun 16;12:695237.","DOI":"10.3389\/fphar.2021.695237"},{"key":"4157_CR58","doi-asserted-by":"crossref","unstructured":"Thome T, Vugman NA, Stone LE, Wimberly K, Scali ST, Ryan TE. A tryptophan-derived uremic metabolite\/Ahr\/Pdk4 axis governs skeletal muscle mitochondrial energetics in chronic kidney disease. JCI Insight. 2024 May 5;9(10).","DOI":"10.1172\/jci.insight.178372"},{"key":"4157_CR59","doi-asserted-by":"crossref","unstructured":"Olaniyi KS, Areloegbe SE. Suppression of PCSK9\/NF\u2013kB-dependent pathways by acetate ameliorates cardiac inflammation in a rat model of polycystic ovarian syndrome. Life Sci. 2022 Jul 1;300:120560.","DOI":"10.1016\/j.lfs.2022.120560"},{"key":"4157_CR60","doi-asserted-by":"crossref","unstructured":"Robles-Vera I, Toral M, de la Visitaci\u00f3n N, Aguilera-S\u00e1nchez N, Redondo JM, Duarte J. Protective effects of short-chain fatty acids on endothelial dysfunction induced by angiotensin II. Front Physiol. 2020 Apr 16;11:277.","DOI":"10.3389\/fphys.2020.00277"},{"key":"4157_CR61","doi-asserted-by":"crossref","unstructured":"Zheng JY, Wang SC, Tang SC, Hsin IL, Kang YT, Hsu CT, Ou CC, Ko JL. Sodium acetate ameliorates cisplatin-induced kidney injury in vitro and in vivo. Chem Biol Interact. 2023 Jan 5;369:110258.","DOI":"10.1016\/j.cbi.2022.110258"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04157-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04157-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04157-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T14:49:02Z","timestamp":1747147742000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04157-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4157"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04157-5","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,13]]},"assertion":[{"value":"9 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was performed in adherence to guidelines from the National Institutes of Health Guide for the Care and maintenance of Laboratory Animals, and the protocol was approved by the Ethical Review Board of Afe Babalola University, Nigeria, with the protocol number ABUADERC\/10\/2023.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"234"}}